{"id":"https://openalex.org/W2506749974","doi":"https://doi.org/10.1182/blood.v104.11.2477.2477","title":"Induction of Multiple Myeloma-Specific Cytotoxic T Lymphocytes Using HLA-A2.1-Specific CD19 and CD20 Peptides.","display_name":"Induction of Multiple Myeloma-Specific Cytotoxic T Lymphocytes Using HLA-A2.1-Specific CD19 and CD20 Peptides.","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2506749974","doi":"https://doi.org/10.1182/blood.v104.11.2477.2477","mag":"2506749974"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.2477.2477","doi":"https://doi.org/10.1182/blood.v104.11.2477.2477","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.2477.2477","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061032029","display_name":"Jooeun E. Bae","orcid":"https://orcid.org/0000-0002-8922-9703","observed_orcids":["https://orcid.org/0000-0002-8922-9703"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jooeun Bae","raw_affiliation_strings":["Department of Medical Oncology, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007893999","display_name":"Jeff Martinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff A. Martinson","raw_affiliation_strings":["Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111951054","display_name":"Hans Klingemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans G. Klingemann","raw_affiliation_strings":["Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081299017","display_name":"Steven Peter Treon","orcid":"https://orcid.org/0000-0001-6393-6154","observed_orcids":["https://orcid.org/0000-0001-6393-6154"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Treon","raw_affiliation_strings":["Department of Medical Oncology, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Department of Medical Oncology, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Department of Medical Oncology, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30623936,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"104","issue":"11","first_page":"2477","last_page":"2477"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.041999999433755875,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.7710000276565552},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":1.0},{"id":"https://openalex.org/keywords/hla-a-0201","display_name":"HLA-A*0201","score":0.9739999771118164},{"id":"https://openalex.org/keywords/immunogenic-peptides","display_name":"immunogenic peptides","score":0.7710000276565552},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.5879999995231628},{"id":"https://openalex.org/keywords/burkitt-lymphoma","display_name":"Burkitt lymphoma","score":0.8980000019073486},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9509999752044678},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.6779999732971191},{"id":"https://openalex.org/keywords/cd69","display_name":"CD69","score":0.597000002861023},{"id":"https://openalex.org/keywords/cd45ro","display_name":"CD45RO","score":0.8820000290870667},{"id":"https://openalex.org/keywords/ctl-expansion","display_name":"CTL expansion","score":0.6380000114440918},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.7456749677658081},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.635918915271759},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.534343421459198},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.48013636469841003},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.46532151103019714},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4363994598388672},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.41110533475875854},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37270987033843994},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3479061424732208},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2488313913345337},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08749553561210632},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.04807594418525696}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.2477.2477","doi":"https://doi.org/10.1182/blood.v104.11.2477.2477","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.2477.2477","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2162917069","https://openalex.org/W2979483560","https://openalex.org/W2056399811","https://openalex.org/W2979601799","https://openalex.org/W1498577864","https://openalex.org/W2589341756","https://openalex.org/W2521302872","https://openalex.org/W2087084002","https://openalex.org/W2149390157","https://openalex.org/W2169031518"],"abstract_inverted_index":{"Abstract":[0],"We":[1,199],"have":[2,217],"identified":[3],"novel":[4],"CD19":[5,105,114,137,141,271],"and":[6,14,35,43,86,115,134,138,195,244,254,272],"CD20":[7,116,139,273],"antigen-derived":[8],"HLA-A2.1-specific":[9],"immunogenic":[10,270],"peptides,":[11],"CD19150\u2013158":[12,63],"(KLMSPKLYV)":[13],"CD20188\u2013196":[15,66],"(SLFLGILSV),":[16],"for":[17],"generating":[18],"cytotoxic":[19,37,51,231],"T":[20],"lymphocytes":[21],"(CTLs)":[22],"against":[23,39,119],"malignant":[24],"B-cell":[25],"diseases.":[26],"Initial":[27],"testing":[28],"showed":[29,201],"that":[30,100,269],"the":[31,54,62,65,69,110,113,172,205,219,240],"CTLs":[32,55,70,174,206,246],"displayed":[33,71],"antigen-specific":[34],"HLA-A2.1-restriced":[36],"activity":[38,52,111,232],"both":[40,136],"Burkitt\u2019s":[41],"lymphoma":[42],"chronic":[44],"lymphoid":[45],"leukemia":[46],"cell":[47,84,94,123,129,155,169,182],"lines.":[48,95,124,170],"The":[49],"observed":[50],"of":[53,112,126,242,262],"was":[56],"shown":[57],"to":[58,61,150,193,197,209,221,247],"be":[59],"specific":[60,196],"or":[64,167,211],"peptides.":[67],"Additionally,":[68],"a":[72,79,190,258,277],"distinct":[73],"phenotype":[74],"(majority":[75],"CD69+/CD45RO+)":[76],"along":[77],"with":[78,91],"significant":[80],"(p<0.05)":[81],"increase":[82],"in":[83,189,252,255,257,281],"proliferation":[85],"IFN-\u03b3":[87,202],"release":[88],"following":[89],"re-stimulation":[90],"HLA-A2.1+/CD19+/CD20+":[92],"tumor":[93],"Based":[96],"on":[97],"emerging":[98],"information":[99],"clonogenic":[101,249],"myeloma":[102,122,128,250],"cells":[103,251],"express":[104],"and/or":[106],"CD20,":[107],"we":[108,216,237],"evaluated":[109,131],"peptide":[117,142],"specific-CTLs":[118,143],"several":[120],"multiple":[121],"Five":[125],"10":[127],"lines":[130,156,183],"were":[132,148],"HLA-A2.1-positive":[133],"expressed":[135],"antigens.":[140,198],"generated":[144,175],"from":[145,176],"normal":[146,177],"donors":[147,178],"able":[149],"specifically":[151],"lyse":[152,165],"CD19+/HLA-A2.1+":[153,210],"MM":[154,181,213],"(30%":[157],"lysis;":[158,185],"10:1":[159,186],"E:T":[160,187],"ratio)":[161],"but":[162],"did":[163],"not":[164],"CD19\u2212/HLA-A2.1+":[166],"CD19+/HLA-A2.1\u2212":[168],"Similarly,":[171],"CD20-specific":[173,245],"lysed":[179],"CD20+/HLA-A2.1+":[180,212],"(25%":[184],"ratio),":[188],"manner":[191],"restricted":[192],"HLA-A2.1":[194],"next":[200],"production":[203],"by":[204],"after":[207],"exposure":[208],"cells.":[214],"Moreover,":[215],"demonstrated":[218],"ability":[220,241],"expand":[222],"CD20-CTLs":[223],"under":[224],"serum-free":[225],"culture":[226],"conditions":[227],"while":[228],"maintaining":[229],"their":[230],"(28\u201349%).":[233],"In":[234],"ongoing":[235],"studies,":[236],"are":[238],"evaluating":[239],"CD19-":[243],"eliminate":[248],"vitro":[253],"vivo":[256],"SCID":[259],"mouse":[260],"model":[261],"myeloma.":[263,282],"These":[264],"preclinical":[265],"studies":[266],"strongly":[267],"suggest":[268],"peptide-based":[274],"vaccines":[275],"represent":[276],"promising":[278],"immunotherapeutic":[279],"approach":[280]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-08-23T00:00:00"}